Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bodhi Tree Biotechnology (BDTB) Return on Sales (2024 - 2025)

Historic Return on Sales for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q4 2025 value amounting to 11.49%.

  • Bodhi Tree Biotechnology's Return on Sales rose 14700.0% to 11.49% in Q4 2025 from the same period last year, while for Dec 2025 it was 11.49%, marking a year-over-year change of. This contributed to the annual value of 8.8% for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Bodhi Tree Biotechnology's Return on Sales stood at 11.49%, which was up 14700.0% from 0.89% recorded in Q3 2025.
  • Bodhi Tree Biotechnology's 5-year Return on Sales high stood at 0.89% for Q3 2025, and its period low was 12.96% during Q4 2024.